MDalert.com is designed to help physicians in all specialties succeed in this new world of performance-driven healthcare.
February 18, 2020

Applying Precision Medicine to Adult Vaccination Schedules May Reduce Burden of Disease

By Jeff Craven, /alert Contributor
The use of a predictive, preventive, personalized, and participatory (P4) medicine approach to create a personalized vaccination schedule for older adults may help reduce their risk of infectious and non-infectious disease later in life...
Applying Precision Medicine to Adult Vaccination Schedules May Reduce Burden of Disease
February 15, 2020

FDA Grants Capmatinib Priority Review for Treatment of Patients With METex14 NSCLC

By Cameron Kelsall, /alert Contributor
The US Food and Drug Administration (FDA) has granted Priority Review to a New Drug Application for the MET inhibitor capmatinib...
FDA Grants Capmatinib Priority Review for Treatment of Patients With METex14 NSCLC
February 12, 2020

Dual EGFR, VEGF Blockade Improves PFS in Patients With Treatment-Naive, EFGR-Mutated NSCLC

By Cameron Kelsall, /alert Contributor
Treatment with the monoclonal antibody ramucirumab, in combination with erlotinib, significantly improved progression-free survival (PFS) when compared with placebo in patients with untreated, EGFR-mutated advanced non–small cell lung cancer...
Dual EGFR, VEGF Blockade Improves PFS in Patients With Treatment-Naive, EFGR-Mutated NSCLC
February 11, 2020

High BMI Associated With Improved Survival with Checkpoint Therapy for Lung Cancer

By Michael Vlessides, /alert Contributor
A new study has found that high body mass index is independently associated with improved survival after atezolizumab therapy in patients with non small-cell lung cancer...
High BMI Associated With Improved Survival with Checkpoint Therapy for Lung Cancer
February 11, 2020

Class 3 BRAF Mutations Demonstrate Higher Response Rate With Anti-EGFR Therapy in CRC

By Michael Vlessides, /alert Contributor
Metastatic colorectal cancer patients with class 3 BRAF mutations are significantly more likely to respond to anti-EGFR therapy than are their counterparts with class 2 BRAF mutations...
Class 3 BRAF Mutations Demonstrate Higher Response Rate With Anti-EGFR Therapy in CRC
View More
Loading...

Trending News

In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.

Reuters Health Medical News

Patients may care less about ER doctor's race, gender than assumed

By Linda Carroll (Reuters Health) - In an online experiment, people gave "simulated" emergency room doctors roughly the same satisfaction rating regardless of the healthcare provider's gender or color Read More »

Surgical jackets and bouffants costly, unlikely to curb site infection risk

By Marilynn Larkin NEW YORK (Reuters Health) - Surgical jackets and bouffants were neither beneficial nor cost-effective in preventing surgical site infections (SSIs) in a study at a large academic Read More »

UPDATE 1-U.S. prepares for coronavirus pandemic, school and business closures -health officials

(Recasts with CDC comments on preparation for community spread, updates headline and byline) By Julie Steenhuysen and Andrew Hay (Reuters) - U.S. health officials on Friday said they are preparing for Read More »

Sepsis a growing problem in people who abuse opioids

By Megan Brooks NEW YORK (Reuters Health) - Overdosing on opioids is not the only health risk for people who abuse these drugs. A new study shows sepsis is an increasing problem among people with Read More »

Researchers discover DNA-methylation signature for schizophrenia

By Reuters Staff NEW YORK (Reuters Health) - Genome-wide blood DNA-methylation data has helped generate a specific signature for schizophrenia, German researchers have found. Previous research found Read More »

U.S. school lunch overhaul tied to healthier meals for kids

By Lisa Rapaport (Reuters Health) - An overhaul of school lunch nutrition standards seems to have driven dramatic improvements in the healthiness of meals served to millions of kids nationwide, a U.S. Read More »

Netflix's 'Stranger Things' raised awareness about rare disorder

By Vishwadha Chander (Reuters Health) - Popular TV shows can help raise awareness and public interest in rare diseases, as the Netflix series "Stranger Things" has done for a little-known bone-growth Read More »

Only three U.S. states can test for coronavirus -public lab group

By Julie Steenhuysen (Reuters) - The U.S. Centers for Disease Control and Prevention is still handling the bulk of testing for the coronavirus as it works out issues with test kits sent to states, and Read More »

See all news »

Featured Video

Major Advances in Urology Care

Major Advances in Urology Care

Guy T. Bernstein, MD, FACS, of Urology Health Specialists discusses major advances in care over the next five years. 

Clinical Trials

Use our ClinicalTrials.gov feed to find trials in which your patients could enroll. In some cases, experimental drugs are a patient’s only hope. This section will regularly report on trials in the most common disease states, as they are getting underway.


© 2020 /alert® unless otherwise noted. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
Privacy Policy | Terms of Use
Do Not Sell My Personal Information